According to these findings, the European Society for Paediatric Gastroenterology, Hepatology and Nutrition guidelines have adopted the no-biopsy approach to diagnose celiac disease in pediatric patients with IgA anti-ttg antibodies positivity >10 times the upper limit of normal, confirmed by EMA finding in a second blood sample (26). This evidence concerns the gene CD79A and celiac disease.